维普中文期刊产品整合服务
18篇 您的检索式:作者名="Zingon A"
    题名 作者 年代 出处 被引量
1The diversity of harmful algal blooms:a challenge for science and management显示文摘ZINGONE A ENEVOLDSEN H 2002Ocean & Coastal Management2002,43,89:1
2CD69-triggered ERK activation and function are negatively regulated by CD94/NKG2-A inhibitory显示文摘Zingon A Palmieri G Morrone S 2000Eur J Immunol2000,30,2:1
3CD69-triggered ERK activation and function are negatively regulated by CD94/NKG2-A inhibitory receptor显示文摘Zingon A Palmieri G Morrone S 2000Eur J Immunol2000,30,2:1
4Deletion polymorphism in the gene for angioten- sin converting enzyme is associated with elevated fasting blood glucose levels 显示文摘Zingone A 1994Hum Genet1994,94,20:1
5The diversity of harmful algal blooms:a challenge for science and management显示文摘Zingone A Enevoldsen H O 0,,:1
6CD69-triggered ERK activation and function are negatively regulated by CD94/NKG2-A inhibitory显示文摘Zingon A Palmieri G Morrone S 2000Eur J Immunol2000,30,2:1
7查看详情显示文摘Zingone A Enevoldsen H O 0,,8:1
8Phase II clinical and correlative study of carfilzomib, lenalidomide, and dexamethasone followed by lenalidomide extended dosing (CRD- R ) induces high rates of mrd negativity in newly diagnosed multiple myeloma ( MM ) patients显示文摘Korde N Zingone A Kwok ML 2013Blood ( ASH Annual Meeting Abstracts)2013,122,21:1
9Seasonal dynamics in the abundance of Micromonas pusilla (Prasinophyceae) and its viruses in the Gulf of Naples (Mediterranean Sea)显示文摘ZINGONE A SARNO D FORLANI G 1999Journal of Plankton Research1999,21,:1
10Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma显示文摘Korde N Roschewski M Zingone A 2015JAMA Oncol2015,1,:1
11Deletion polymorphism in the gene for angiotensin concerting enzyme is associated with elevated fasting blood glucose levels显示文摘Zingone A Dominijanni A Mele E Hum Genet0,94,2:1
12Morphological and genetic characterization of Phaeocystis cordata and Phaeocystis jahnii(Prymnesiophyceae),two new species from the Mediterranean Sea显示文摘Zingone A Chretiennot-Dinet M J Lange M 1999J Phycol1999,35,:1
13Phase Ⅱ clinical and correlative study of carfilzomib,lenalidomide,and dexamethasone followed by lenalidomide extended dosing (CRD-R) induces high rates of MRD negativity in newly diagnosed multiplemyeloma (MM) Patients显示文摘Korde N Zingone A Kwok ML 2013Blood2013,122,21:1
14Classical and/or alternative NF-kappaB pathway activation in multiple myeloma显示文摘DEMCHENKO Y N GLEBOV O K ZINGONE A 2010Blood2010,115,:1
15The diversity of harmful algal blooms: a challenge for science and management 显示文摘Zingone A Enevoldsen H O 2000Ocean and Coastal Management2000,43,:1
16The diversity of harmful blooms: a challenge for science and management显示文摘Zingone A Oksfeldt - Eneroldsen H 2000Ocean and Coastal Management2000,43,:1
17The diversity of harmful algal blooms: a challenge for science and management 显示文摘Zingone A Enevoldsen H O 2000Ocean and Coastal Management2000,43,:1
18Upper gastrointestinal endoscopic findings in celiac disease at diagnosis:A multicenter international retrospective study显示文摘BACKGROUND Gastroduodenal endoscopy and biopsy following positive specific serology is considered the gold standard to diagnose celiac disease(CeD)in adults.Whether upper endoscopy helps detect comorbid conditions is unknown.AIM To investigate the prevalence of non-celiac endoscopic findings in patients in whom endoscopy was performed to confirm CeD diagnosis.METHODS This is an observational,descriptive,multicenter,retrospective study that reports endoscopic findings obtained in adult patients enrolled in local registries from four tertiary centers.We collected data reported on first endoscopy,indicated for investigation of CeD.Diagnosis of CeD was performed by histology(≥Marsh 2type mucosal damage)and specific serology.Two European and one North American center included biopsy-confirmed CeD following positive serology.A fourth center(South America)included symptomatic patients undergoing endoscopy,irrespective of CeD serology.The latter cohort included a non-CeD control group.RESULTS A total of 1328 patients(80%female;35 years median age)were enrolled,of whom 95.6%had positive specific serology.In 135 patients,endoscopy revealed 163 abnormalities unrelated to CeD(prevalence:10.1%).Erosive reflux esophagitis(6.4%),gastric erosions(2.0%),and suspicion of esophageal metaplasia(1.2%)were the most common findings.Biopsy-confirmed Barrett’s esophagus was infrequent(0.2%).No endoscopic cancer was detected.Older patients(≥51 years of age)had a higher prevalence of endoscopic findings than those≤50(P<0.01).Within the South American cohort,CeD was associated with a lower rate(8.2%)of comorbid endoscopic findings compared with controls(29.1%;P<0.001).In the adjusted multivariate analysis of this cohort,having CeD was associated with a 72%reduction in the risk of any endoscopic abnormality(P<0.0001),and having alarm symptoms was associated with a 37%reduction in the risk of finding at least one endoscopic lesion(P<0.02).CONCLUSION In this large multicenter study,young adults with positive CeD serology had few comorbid endoscopic findings.Although patients over 51 years had a high prevalence of non-CeD gastroduodenal mucosal damage,no malignancy or premalignant lesions were found.Juan Pablo Stefanolo Fabiana Zingone Carolina Gizzi Ilaria Marsilio María Luján Espinet Edgardo GustavoSmecuol Mark Khaouli María Laura Moreno María I Pinto-Sánchez Sonia Isabel Niveloni Elena F Verdú Carolina Ciacci Julio César Bai 2022World Journal of Gastroenterology2022,28,43:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费